SEC Form 4 · accession 0001144204-15-043756
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anand Mehra
Director · 10% Owner
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 8:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $14.30 | Jul 20, 2015 | A | 6,300 | A | — | Jul 20, 2025 | Common Stock | 6,300 | 6,300 | D |
Explanation of responses
- F11,050 options vest on September 30, 2015 and the remaining options vest on the last day of the month in 10 equal monthly installments commencing 10/31/2015.